US researchers say they're one step closer to developing an Ebola vaccine, but it will be months before it can be used in the field.

Pharmaceutical companies are scrambling to fast-track experimental drugs and vaccines that could help fight the deadly tropical virus.

In the first phase of testing, all 20 healthy adults injected with a higher or lower dose of the vaccine developed antibodies needed to fight Ebola.